布地奈德联合沙丁胺醇雾化吸入治疗支气管肺炎疗效观察

Outcomes of combined budesonide with salbutamol for bronchial pneumonia via aerosol inhalation

目的:观察布地奈德联合沙丁胺醇雾化吸入治疗支气管肺炎的临床疗效。方法:将80例支气管肺炎患儿随机分为治疗组和对照组各40例。对照组给予常规治疗,治疗组在常规治疗的基础上给予布地奈德联合沙丁胺醇雾化吸入治疗。结果:治疗组气喘及咳嗽缓解天数、肺部喘鸣音消失天数及住院天数均少于对照组。两组均无不良反应发生。结论:布地奈德联合沙丁胺醇雾化吸入治疗支气管肺炎是一种安全、有效的治疗方法,可有效减轻患儿咳喘症状,缩短住院时间,值得临床推广。

Objective： To observe the therapeutic effects of combined budesonide with salbutamol for bronchial pneumonia through aerosol inhalation.Methods： Eighty children with bronchial pneumonia were randomized into treatment group and control group（ n = 40 for each）. The control group received conventional medication,and the treatment group were given additional budesonide and salbutamol via aerosol inhalation on conventional regimen basis.Results： The treatment group had shortened duration of asthma and cough,early disappearance of lung wheezing sound and reduced hospital stay. No adverse effects occurred in the two groups. Conclusion： Aerosol inhalation of combined budesonide with for can be safe and effective for treatment of bronchial pneumonia in children,and is worthy of wider clinical recommendation,for it has advantages of effective relief of the asthma symptoms and reduction of hospital stay.